Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, San Francisco
With
National Institute on Aging (NIA)
Thirteen individuals with aMCI received eight 60-minute sessions of 40-Hz (gamma) transcranial alternating current stimulation (tACS) in a single-arm design. Outcome measures were assessed pre- and post-intervention.
Age
55–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
English speaking
Grade 12 or more education
Normal or corrected to normal vision and hearing
Ability to complete cognitive tasks
Ability to cooperate and comply with all study procedures
Ability to tolerate tACS
Self-reported memory complaint
Diagnosed with mild cognitive impairment
Amyloid positive
You may not be if
Neurological or psychiatric disorders other than mild cognitive impairment
Receiving investigational medications or have participated in a trial with investigational medications within last 30 days
Family history of epilepsy
Implanted electronic devices (e.g., pacemaker)
Prior head trauma
Pregnant
IQ \< 80
Taking cholinesterase inhibitory, memantine, or psychotropic medication
Taking anti-depressants or anti-anxiety medication
